Voyageur Pharmaceuticals converts $192,300 debt into equity via share issuance

• Voyageur Pharmaceuticals completed a shares-for-debt settlement covering $192,300 of outstanding indebtedness.
• Debt was converted into 1,240,644 common shares at a deemed price of $0.155 per share.
• The company used equity issuance to preserve cash.
• Shares issued in the settlement carry a four-month-and-one-day hold period from issuance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyageur Pharmaceuticals Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610021629NEWSFILECNPR____20261002_317210_1) on October 02, 2026, and is solely responsible for the information contained therein.